Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Adams

Showing results (471-480 of 602) with videos related to

Pageof 61
Sort By:
Nature Communications|May 4, 2019
MEK1/2 inhibitor withdrawal reverses acquired resistance driven by BRAF<sup>V600E</sup> amplification whereas KRAS<sup>G13D</sup> amplification promotes EMT-chemoresistanceMatthew J Sale, Kathryn Balmanno, Jayeta Saxena, et al.
ACS Central Science|May 30, 2023
Proximity-Induced Nucleic Acid Degrader (PINAD) Approach to Targeted RNA Degradation Using Small MoleculesSigitas Mikutis, Maria Rebelo, Eliza Yankova, et al.
Nature Genetics|December 10, 2013
Inactivating CUX1 mutations promote tumorigenesisChi C Wong, Inigo Martincorena, Alistair G Rust, et al.
Plos One|March 7, 2019
FBXO7 sensitivity of phenotypic traits elucidated by a hypomorphic alleleCarmen Ballesteros Reviriego, Simon Clare, Mark J Arends, et al.
Cancer Research|January 14, 2010
Insertional mutagenesis in mice deficient for p15Ink4b, p16Ink4a, p21Cip1, and p27Kip1 reveals cancer gene interactions and correlations with tumor phenotypesJaap Kool, Anthony G Uren, Carla P Martins, et al.
Biology Open|July 24, 2019
The <i>Col4a2<sup>em1(IMPC)Wtsi</sup></i> mouse line: lessons from the Deciphering the Mechanisms of Developmental Disorders programLukas F Reissig, Anna Nele Herdina, Julia Rose, et al.
Familial Cancer|October 5, 2015
Germline TERT promoter mutations are rare in familial melanomaMark Harland, Mia Petljak, Carla Daniela Robles-Espinoza, et al.
American Journal of Human Genetics|June 6, 2025
Validating data from multiplex assays of variant effect: A CanVIG-UK national survey of NHS clinical scientistsSophie Allen, Alice Garrett, Charlie F Rowlands, et al.
Nature Communications|November 29, 2017
Stem cell senescence drives age-attenuated induction of pituitary tumours in mouse models of paediatric craniopharyngiomaJose Mario Gonzalez-Meljem, Scott Haston, Gabriela Carreno, et al.
Genomics|November 14, 2009
Genome-wide end-sequenced BAC resources for the NOD/MrkTac() and NOD/ShiLtJ() mouse genomesCharles A Steward, Sean Humphray, Bob Plumb, et al.
Pageof 61

Showing results (471-480 of 602) with videos related to

Sort By:
Pageof 61
Nature Communications|May 4, 2019
MEK1/2 inhibitor withdrawal reverses acquired resistance driven by BRAF<sup>V600E</sup> amplification whereas KRAS<sup>G13D</sup> amplification promotes EMT-chemoresistanceMatthew J Sale, Kathryn Balmanno, Jayeta Saxena, et al.
ACS Central Science|May 30, 2023
Proximity-Induced Nucleic Acid Degrader (PINAD) Approach to Targeted RNA Degradation Using Small MoleculesSigitas Mikutis, Maria Rebelo, Eliza Yankova, et al.
Nature Genetics|December 10, 2013
Inactivating CUX1 mutations promote tumorigenesisChi C Wong, Inigo Martincorena, Alistair G Rust, et al.
Plos One|March 7, 2019
FBXO7 sensitivity of phenotypic traits elucidated by a hypomorphic alleleCarmen Ballesteros Reviriego, Simon Clare, Mark J Arends, et al.
Cancer Research|January 14, 2010
Insertional mutagenesis in mice deficient for p15Ink4b, p16Ink4a, p21Cip1, and p27Kip1 reveals cancer gene interactions and correlations with tumor phenotypesJaap Kool, Anthony G Uren, Carla P Martins, et al.
Biology Open|July 24, 2019
The <i>Col4a2<sup>em1(IMPC)Wtsi</sup></i> mouse line: lessons from the Deciphering the Mechanisms of Developmental Disorders programLukas F Reissig, Anna Nele Herdina, Julia Rose, et al.
Familial Cancer|October 5, 2015
Germline TERT promoter mutations are rare in familial melanomaMark Harland, Mia Petljak, Carla Daniela Robles-Espinoza, et al.
American Journal of Human Genetics|June 6, 2025
Validating data from multiplex assays of variant effect: A CanVIG-UK national survey of NHS clinical scientistsSophie Allen, Alice Garrett, Charlie F Rowlands, et al.
Nature Communications|November 29, 2017
Stem cell senescence drives age-attenuated induction of pituitary tumours in mouse models of paediatric craniopharyngiomaJose Mario Gonzalez-Meljem, Scott Haston, Gabriela Carreno, et al.
Genomics|November 14, 2009
Genome-wide end-sequenced BAC resources for the NOD/MrkTac() and NOD/ShiLtJ() mouse genomesCharles A Steward, Sean Humphray, Bob Plumb, et al.
Pageof 61